Cargando…
Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options
Seizures are clinically significant manifestations associated with 79%–90% of patients with tuberous sclerosis complex. Often occurring within the first year of life in the form of infantile spasms, seizures interfere with neuropsychiatric, social, and cognitive development and carry significant ind...
Autores principales: | Wang, Shelly, Fallah, Aria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211915/ https://www.ncbi.nlm.nih.gov/pubmed/25364257 http://dx.doi.org/10.2147/NDT.S51789 |
Ejemplares similares
-
Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives
por: Overwater, Iris E, et al.
Publicado: (2019) -
Changing Global Trends in Seizure Outcomes Following Resective Surgery for Tuberous Sclerosis in Children with Medically Intractable Epilepsy
por: Ibrahim, George M., et al.
Publicado: (2012) -
Monitoring and Managing Patients with Tuberous Sclerosis Complex: Current State of Knowledge
por: Gomes, Inês, et al.
Publicado: (2022) -
Everolimus dosing recommendations for tuberous sclerosis complex–associated refractory seizures
por: Franz, David N., et al.
Publicado: (2018) -
Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex—Current Views on Their Pathogenesis and Management
por: Gao, Chao, et al.
Publicado: (2023)